Boston and EndoTex make carotid stenting strides
This article was originally published in Clinica
Executive Summary
Researchers have completed the enrolment phase of a US clinical trial assessing the use of EndoTex Interventional Systems' carotid stent with Boston Scientific's embolic protection system as a less-invasive treatment for patients with carotid artery disease for whom traditional surgery is too risky.